ANNOUNCEMENT

Dr. Wendy Chung Honored with RARE Champion in Health Equity Award

I am deeply honored to receive the Health Equity Award from Global Genes. This recognition holds special meaning as it highlights the importance of ensuring that all individuals, especially those in the rare genetic disease community, have access to the care, resources, and research they need. I’m proud to be part of this effort, and I remain committed to advancing health equity for everyone impacted by rare conditions.

Wendy Chung, MD, PhD, Principal Investigator, Simons Searchlight

 

Dr. Chung accepting the award at the Global Genes ceremony

We’re excited to announce that Dr. Wendy Chung, Principal Investigator of Simons Searchlight, has been honored with the RARE Champion in Health Equity Award at the Global Genes RARE Champions of Hope Ceremony!

About the Award:

This recognition is given to individuals who have developed innovative programming or meaningful approaches to address systemic challenges contributing to inequities within the rare disease community. It highlights efforts to tackle disparities, empower underserved populations, and create lasting change in rare disease care.

Dr. Chung’s decades of dedication to advancing research, care, and support for those affected by rare genetic neurodevelopmental disorders have made a significant impact. Her work as a committed advocate for underrepresented communities has shaped more inclusive healthcare systems. She also leads the GUARDIAN study, which focuses on advancing health equity and early diagnosis for rare genetic diseases.

At Simons Searchlight, we are inspired every day by Dr. Chung’s visionary leadership. Her commitment to improving the lives of those in need continues to drive our mission of empowering rare disease communities worldwide.

Please join us in congratulating Dr. Wendy Chung on this well-deserved recognition!

You can read more about Dr. Chung’s accomplishments in her interview with Rare Revolution Magazine. 

Follow Our Progress

Sign up for the Simons Searchlight newsletter.